Treatment with Arthrospira, a genus of free-floating filamentous cyanobacteria, increased serum IFN-γ levels but decreased serum TNF-α and IL-6 and hepatic fibrosis and steatosis in CHB patients receiving NA therapy. This evidence concerns the gene TNF and steatosis.